comparemela.com

Latest Breaking News On - Orphazymeas orphazyme - Page 6 : comparemela.com

Pomerantz Law Firm Announces the Filing of a Class Action Against Orphazyme A/S and Certain Officers and Directors

Share this article Share this article NEW YORK, July 9, 2021 /PRNewswire/  Pomerantz LLP announces that a class action lawsuit has been filed against Orphazyme A/S ( Orphazyme or the Company ) (NASDAQ: ORPH) and certain of its officers and directors. The class action, filed in the United States District Court for the Northern District of Illinois, Eastern Division, and docketed under 21-cv-03640, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Orphazyme American depositary shares ( ADSs ) pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company s initial public offering conducted on or about September 29, 2020 (the IPO or Offering ); and/or (b) Orphazyme securities between September 29, 2020 and June 18, 2021, both dates inclusive (the Class Period ). Plaintiff pursues claims against the Defendants under the Securities Act of 1933 (the Securitie

Pomerantz Law Firm Announces the Filing of a Class Action Against Orphazyme A/S and Certain Officers and Directors - ORPH - Press Release

NEW YORK, July 9, 2021 /PRNewswire/  Pomerantz LLP announces that a class action lawsuit has been filed against Orphazyme A/S (“Orphazyme” or the “Company”) (NASDAQ:ORPH) and certain of its officers and directors. The class action, filed in the United States District Court for the Northern District of Illinois, Eastern Division, and docketed under 21-cv-03640, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Orphazyme American depositary shares (“ADSs”) pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about September 29, 2020 (the “IPO” or “Offering”); and/or (b) Orphazyme securities between September 29, 2020 and June 18, 2021, both dates inclusive (the “Class Period”). Plaintiff pursues claims against the Defendants under the Securities Act of 1933 (the “Securities Act”) and

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.